Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders Volume 4, 2003 - Issue 3
Journal homepage
53
Views
20
CrossRef citations to date
0
Altmetric
Original research

The serotonin precursor 5‐hydroxytryptophan delays neuromuscular disease in murine familial amyotrophic lateral sclerosis

BJ Turner Neurodegeneration Research Laboratory, Department of Anatomy and Cell Biology, Monash University, Victoria, Australia
,
EC Lopes Neurodegeneration Research Laboratory, Department of Anatomy and Cell Biology, Monash University, Victoria, Australia
&
SS Cheema Neurodegeneration Research Laboratory, Department of Anatomy and Cell Biology, Monash University, Victoria, AustraliaCorrespondence[email protected]
Pages 171-176 | Received 17 Dec 2002, Accepted 09 Apr 2003, Published online: 10 Jul 2009

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

REUVEN SANDYK. (2006) SEROTONERGIC MECHANISMS IN AMYOTROPHIC LATERAL SCLEROSIS. International Journal of Neuroscience 116:7, pages 775-826.
Read now

Articles from other publishers (19)

Lu Yang, Yanfei Cheng, Yicheng Zhu, Liying Cui & Xiaoguang Li. (2023) The Serotonergic System and Amyotrophic Lateral Sclerosis: A Review of Current Evidence. Cellular and Molecular Neurobiology 43:6, pages 2387-2414.
Crossref
Jennifer A. Fifita, Sandrine Chan Moi Fat, Emily P. McCann, Kelly L. Williams, Natalie A. Twine, Denis C. Bauer, Dominic B. Rowe, Roger Pamphlett, Matthew C. Kiernan, Vanessa X. Tan, Ian P. Blair & Gilles J. Guillemin. (2021) Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis. Frontiers in Immunology 12.
Crossref
Alizée Arnoux & Luc Dupuis. 2021. 5-HT2B Receptors. 5-HT2B Receptors 367 386 .
Fabian Kreilaus, Stefan Guerra, Rebecca Masanetz, Victoria Menne, Justin Yerbury & Tim Karl. (2019) Novel behavioural characteristics of the superoxide dismutase 1 G93A ( SOD1 G93A ) mouse model of amyotrophic lateral sclerosis include sex‐dependent phenotypes . Genes, Brain and Behavior 19:2.
Crossref
Megan M. Haney, Joseph Sinnott, Kate L. Osman, Ian Deninger, Ellyn Andel, Victoria Caywood, Alexis Mok, Brayton Ballenger, Kevin Cummings, Lori Thombs & Teresa E. Lever. (2019) Mice Lacking Brain‐Derived Serotonin Have Altered Swallowing Function. Otolaryngology–Head and Neck Surgery 161:3, pages 468-471.
Crossref
Yannick Vermeiren, Jana Janssens, Debby Van Dam & Peter P. De Deyn. (2018) Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes. Frontiers in Neuroscience 12.
Crossref
Hajer El Oussini, Hanna Bayer, Jelena Scekic-Zahirovic, Pauline Vercruysse, Jérôme Sinniger, Sylvie Dirrig-Grosch, Stéphane Dieterlé, Andoni Echaniz-Laguna, Yves Larmet, Kathrin Müller, Jochen H. Weishaupt, Dietmar R. Thal, Wouter van Rheenen, Kristel van Eijk, Roland Lawson, Laurent Monassier, Luc Maroteaux, Anne Roumier, Philip C. Wong, Leonard H. van den Berg, Albert C. Ludolph, Jan H. Veldink, Anke Witting & Luc Dupuis. (2016) Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis. Acta Neuropathologica 131:3, pages 465-480.
Crossref
Stephen R. Pfohl, Martin T. Halicek & Cassie S. Mitchell. (2015) Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis. Journal of Neuromuscular Diseases 2:2, pages 137-150.
Crossref
Marta Ruiz, Ana Fe Martínez-Vidal, José Manuel Morales, Daniel Monleón & Minerva Giménez y Ribotta. (2014) Neurodegenerative changes are prevented by Erythropoietin in the pmn model of motoneuron degeneration. Neuropharmacology 83, pages 137-153.
Crossref
J. E. KoschnitzkyK. A. QuinlanT. J. LukasE. KajtazE. J. KocevarW. F. MayersT. Siddique & C. J. Heckman. (2014) Effect of fluoxetine on disease progression in a mouse model of ALS. Journal of Neurophysiology 111:11, pages 2164-2176.
Crossref
Pierre-François Pradat & Luc Dupuis. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity 1417 1434 .
Angelina Cistaro, Maria Consuelo Valentini, Adriano Chiò, Flavio Nobili, Andrea Calvo, Cristina Moglia, Anna Montuschi, Silvia Morbelli, Dario Salmaso, Piercarlo Fania, Giovanna Carrara & Marco Pagani. (2011) Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. European Journal of Nuclear Medicine and Molecular Imaging 39:2, pages 251-259.
Crossref
Luc Dupuis, Odile Spreux-Varoquaux, Gilbert Bensimon, Philippe Jullien, Lucette Lacomblez, François Salachas, Gaëlle Bruneteau, Pierre-François Pradat, Jean-Philippe Loeffler & Vincent Meininger. (2010) Platelet Serotonin Level Predicts Survival in Amyotrophic Lateral Sclerosis. PLoS ONE 5:10, pages e13346.
Crossref
Anna Casanovas, Sara Hernández, Olga Tarabal, Jaume Rosselló & Josep E. Esquerda. (2007) Strong P2X 4 purinergic receptor‐like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis . Journal of Comparative Neurology 506:1, pages 75-92.
Crossref
Michael Benatar. (2007) Lost in translation: Treatment trials in the SOD1 mouse and in human ALS. Neurobiology of Disease 26:1, pages 1-13.
Crossref
Richard A Smith & Ben R Brooks. (2005) Treatment of pseudobulbar affect in ALS. The Lancet Neurology 4:5, pages 270.
Crossref
Vincent Meininger. (2005) Treatment of emotional lability in ALS. The Lancet Neurology 4:2, pages 70.
Crossref
Edith G McGeer & Patrick L McGeer. (2005) Pharmacologic Approaches to the Treatment of Amyotrophic Lateral Sclerosis. BioDrugs 19:1, pages 31-37.
Crossref
B.J. Turner, A. Rembach, R. Spark, E.C. Lopes & S.S. Cheema. (2003) Opposing effects of low and high‐dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice. Journal of Neuroscience Research 74:4, pages 605-613.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.